Date: 2024/12/06 - 00:00
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a clinical trial show 20% of participants who took Zepbound achieved significant weight loss compared to nearly 14% of participants who took Wegovy.
Date: 2024/12/05 - 15:31
A new report has identified several factors that can strongly predict at age 60 if people will develop dementia by 80, including having diabetes, not exercising, having a stroke, and not engaging in hobbies.
Date: 2024/11/27 - 15:00
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to general weight loss. Is this a real concern, and if so, how can a person maintain their muscle mass on GLP-1 drugs?